Curaleaf (OTCMKTS:CURLF) Announces Earnings Results

Curaleaf (OTCMKTS:CURLF) announced its earnings results on Tuesday. The company reported ($0.14) earnings per share for the quarter, beating the consensus estimate of ($0.16) by $0.02, Zacks reports. Curaleaf had a negative return on equity of 0.88% and a negative net margin of 2.62%.

Curaleaf Stock Performance

OTCMKTS CURLF opened at $10.12 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 0.73 and a debt-to-equity ratio of 1.06. The company has a market capitalization of $2.36 billion, a PE ratio of -77.85 and a beta of 1.62. The business’s 50-day moving average price is $9.56 and its 200 day moving average price is $8.31. Curaleaf has a twelve month low of $5.40 and a twelve month high of $15.15.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on CURLF. Zacks Research downgraded Curaleaf from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 13th. Citigroup reiterated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Finally, UBS Group set a $6.00 target price on Curaleaf in a report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $6.00.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted.